Slide 11 www.cinbo.org O n c o l o Together for y LOncologia insieme per L*Aquila G Bruera, D Di Giacomo & E Ricevuto Medical Oncology Department Experimental Medicine…

Slide 1New Strategies on Horizon Tony Mok MD Dept of Clinical Oncology The Chinse University of Hong Kong Slide 2 TKI is forever Addressing the difference Novel Target Slide…

Slide 1Extending life for women with HER2-positive MBC Andreas Makris Mount Vernon Hospital Middlesex, UK Slide 2 1 Yamamoto et al 2008; 2 Xu et al 2006; 3 von Minckwitz…

Slide 1 Novel Agents for Indolent Lymphoma and Mantle Cell Lymphoma Stephen Ansell, MD, PhD Mayo Clinic Slide 2 Tiacci et al, Nature Reviews Cancer 6, 437-448, 2006. Would…

Slide 1 Harnessing the Power of the Host Immune System to Fight Cancer Robert Kastelein Immuno-Oncology Discovery Texas FreshAIR Conference 2014 Houston October 23-24 Slide…

Slide 1 Results of a Randomized Phase III Trial (MPACT) of Weekly nab-Paclitaxel Plus Gemcitabine vs Gemcitabine Alone for Patients With Metastatic Adenocarcinoma of the…

Novel agents for indolent lymphoma and MCL Novel Agents for Indolent Lymphoma and Mantle Cell Lymphoma Stephen Ansell, MD, PhD Mayo Clinic 1 Tiacci et al, Nature Reviews…

New Strategies on Horizon Tony Mok MD Dept of Clinical Oncology The Chinse University of Hong Kong TKI is forever Addressing the difference Novel Target TKI is forever 5cm…